Stockscreener 앱 받기
71.73
0.52%
0.37
Solventum Corp 주식(SOLV)의 최신 뉴스
What institutional investors are buying Solventum Corporation stockMarket Forecast Recommendation With Low Risk - jammulinksnews.com
11 Best Medical Stocks to Buy According to Analysts - Insider Monkey
Stock Analysis | Solventum OutlookTechnical Weakness and Analyst Disagreement Cloud Near-Term Prospects - AInvest
Building trade automation scripts for Solventum CorporationReal Trader Watchlist of Hot Stocks Released - metal.it
Why Solventum Corporation stock attracts strong analyst attentionDaily Growth Stock Pick Reports Show Bullish Signals - metal.it
Advanced Wound Care Market to Hit $19.32 Billion by 2030 – What’s Fueling the Surge? | MarketsandMarkets™. - GlobeNewswire Inc.
What makes Solventum Corporation stock price move sharplyTarget Return Focused Trade Insights Shared - beatles.ru
What are the latest earnings results for Solventum CorporationOutstanding risk-reward balance - jammulinksnews.com
Is it the right time to buy Solventum Corporation stockBuild wealth with reliable stock picks - jammulinksnews.com
How many analysts rate Solventum Corporation as a “Buy”Discover high-impact stocks for growth - jammulinksnews.com
When is Solventum Corporation stock expected to show significant growthTrack high-yield stocks before they peak - jammulinksnews.com
Assessing the Strategic and Financial Implications of 3M's Spin-Off of Solventum - AInvest
3M Company: Adjusting to Solventum Spinoff and MMM Stock Performance - AInvest
3M Company: Still Adjusting To Spinoff Of Solventum (NYSE:MMM) - Seeking Alpha
What are Solventum Corporation company’s key revenue driversExceptional return forecasts - jammulinksnews.com
What to Expect From Solventum's Q2 2025 Earnings Report - MSN
Solventum Corporation Stock Analysis and ForecastConsistently high yield - PrintWeekIndia
Solventum Corporation's Anticipated Q2 2025 Earnings ReleaseNews and Statistics - IndexBox
What To Expect From Solventum's Q2 2025 Earnings Report - Barchart.com
Solventum to Report Second Quarter Fiscal 2025 Earnings on August 7, 2025 - StreetInsider
Lobbying Update: $60,000 of SOLVENTUM lobbying was just disclosed - Quiver Quantitative
What analysts say about Solventum Corporation stockExtraordinary market timing - jammulinksnews.com
Solventum: Appealing Again (NYSE:SOLV) - Seeking Alpha
Is Solventum Corporation a good long term investmentExceptional growth trajectory - jammulinksnews.com
What drives Solventum Corporation stock priceOutstanding trading profits - jammulinksnews.com
Steris, Solventum upgraded, RxSight downgraded in Morgan Stanley's MedTech review - MSN
As more Minnesota companies rethink remote work, Solventum and others hold the line on flexibility - MSN
Earnings Alert: Solventum Sets Q2 2025 Report Date, Management to Discuss Future Outlook - Stock Titan
Steris, Solventum stocks upgraded at Morgan Stanley (STE:NYSE) - Seeking Alpha
Morgan Stanley upgrades Solventum stock rating to Overweight on margin potential By Investing.com - Investing.com South Africa
Morgan Stanley upgrades Solventum stock rating to Overweight on margin potential - Investing.com India
Morgan Stanley Upgrades Solventum to Overweight From Equalweight, Adjusts PT to $103 From $80 - MarketScreener
0.92%
자본화:
|
볼륨(24시간):